Physician profile
Athanasios Desalermos
NPI 1982961066
$5,017.05
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $659 · 2021: $1,767 · 2022: $1,426 · 2023: $12.75 · 2024: $51.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,405.35 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $914.58 | 2020-2022 | |
| Abbvie INC. | $564.79 | 2019-2023 | Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $512.14 | 2019-2022 | |
| Pfizer INC. | $428.78 | 2019-2022 | |
| Braintree Laboratories, INC. | $254.67 | 2019-2022 | |
| Gilead Sciences, INC. | $157.24 | 2021-2024 | |
| Intercept Pharmaceuticals, INC. | $133.12 | 2019-2022 | |
| Janssen Biotech, INC. | $99.73 | 2021-2022 | |
| Redhill Biopharma INC. | $96.18 | 2020-2022 | |
| Allergan, INC. | $87.70 | 2019 | |
| Celgene Corporation | $81.97 | 2021-2022 | |
| Ucb, INC. | $52.08 | 2019-2020 | |
| Conmed Corporation | $49.22 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $45.50 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $35.92 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $23.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $23.42 | 2022 | |
| Qol Medical, LLC | $20.82 | 2022 | |
| Daiichi Sankyo INC. | $18.42 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athanasios Desalermos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.